Combined transcervical radiofrequency ablation and hysteroscopic myomectomy: expanding treatment to diverse fibroid types
Authors:
Open Access
- 22 July 2025
- journal article
- research article
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 312 (4) , 1-6
Abstract
Introduction: Uterine fibroids are highly prevalent and often symptomatic, leading to abnormal uterine bleeding (AUB) and impaired quality of life. While hysteroscopic myomectomy (HSC) is the gold-standard treatment for submucosal fibroids, it is limited in addressing deeper lesions. Transcervical radiofrequency ablation (TFA) offers a minimally invasive alternative for intramural and transmural fibroids. This study evaluated the safety and effectiveness of combining TFA with HSC in a single session compared to HSC alone. Study design: We conducted a retrospective multicenter analysis of 127 women with symptomatic fibroids and AUB. Patients underwent either combined TFA + HSC (n = 75) or HSC alone (n = 52). Outcomes included intraoperative bleeding, complications, and symptom improvement. Results: The combined group treated a broader range of fibroid types (FIGO 0–6) and larger fibroids (mean size 2.86 cm vs. 2.23 cm; p = 0.0013). Intraoperative bleeding was significantly lower in the combined group (0% vs. 9.6%; p = 0.0102), with no increase in total complication rates (8% vs. 15%; p = 0.2512). Among patients with follow-up data, 85.1% reported symptom improvement after combined treatment. Conclusion: Combining TFA with hysteroscopic myomectomy is a safe and effective approach that expands the range of treatable fibroids, reduces intraoperative bleeding, and maintains high patient satisfaction. This integrated strategy offers advantages in tissue diagnosis, potential cost savings, and uterine preservation, making it a valuable addition to minimally invasive fibroid management.Keywords
Funding Information
- Private Universität Witten/Herdecke gGmbH
This publication has 15 references indexed in Scilit:
- The significance of transcervical ultrasound-guided radiofrequency ablation in the treatment of symptomatic fibroids: results of an expert consensus from German-speaking countriesArchives of Gynecology and Obstetrics, 2022
- Transcervical fibroid ablation with the Sonata™ system for treatment of submucous and large uterine fibroidsInternational Journal of Gynecology & Obstetrics, 2021
- A New Paradigm for Uterine Fibroid Treatment: Transcervical, Intrauterine Sonography-Guided Radiofrequency Ablation of Uterine Fibroids with the Sonata SystemCurrent Obstetrics and Gynecology Reports, 2017
- The FAST-EU trial: 12-month clinical outcomes of women after intrauterine sonography-guided transcervical radiofrequency ablation of uterine fibroidsGynecological Surgery, 2015
- Uterine FibroidsNew England Journal of Medicine, 2013
- The impact of uterine leiomyomas: a national survey of affected womenAmerican Journal of Obstetrics and Gynecology, 2013
- Uterine myomas: managementFertility and Sterility, 2007
- A prospective randomized controlled trial on the effectiveness of routine Foley balloon tamponade on the reduction of bleeding after hysteroscopic resection of myomaGynecological Surgery, 2006
- Uterine fibroidsThe Lancet, 2001
- Long-term results of hysteroscopic myomectomy for abnormal uterine bleedingObstetrics & Gynecology, 1999